Ivermectin as a potential treatment for mild to moderate COVID-19–a double blind randomized placebo-controlled trial

Ravikirti, R Roy, C Pattadar, R Raj, N Agarwal… - MedRxiv, 2021 - medrxiv.org
Objective Ivermectin has been suggested as a treatment for COVID-19.This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Ivermectin as a potential treatment for mild to moderate COVID-19: A double blind randomized placebo-controlled trial (preprint)

R Kirti, R Roy, C Pattadar, R Raj, N Agarwal, B Biswas… - 2021 - pesquisa.bvsalud.org
Objective: Ivermectin has been suggested as a treatment for COVID-19. This randomised
control trial was conducted to test the efficacy of Ivermectin in the treatment of mild and …

Ivermectin and Statistical Significance: At What Point Should a Potential Therapy Be Deemed Effective?

CL Hooper, DR Henderson - Regulation, 2022 - HeinOnline
Ivermectin, which is the generic name for the drug, was discovered in 1975 by William Campbell
of the Merck Institute for Therapeutic Research and Satoshi Omura of Kitasato University…

[PDF][PDF] IVERMECTIN: COVID-19 MIRACLE CURE OR CRUEL HOAX?

P Machanick - 2021 - researchgate.net
Background There has been a massive social media campaign to promote ivermectin as the
drug of choice to prevent and treat COVID-19. I review here the evidence used by the most …

[HTML][HTML] A comparison of Ivermectin and Non Ivermectin based regimen for covid 19 in Abuja: effects on virus clearance, Days-to-Discharge and Mortality.

B OE, AA Ajayi, O JO - 2022 - europepmc.org
Aim: To compare outcomes from ivermectin (IVM)-and non-ivermectin (NIVM)-based treatments
for COVID-19 in Abuja, Nigeria. Methods: Sixty-one consecutive virology-proven cases …

to Food'

KW Costello - Regulation, 2022 - HeinOnline
REGULATION, Vol. 45 No. 1 (ISSN 0147-0590). Copyright 2022, Cato Institute. REGULATION
is published four times a year by the Cato Institute. Views expressed in REGULATION …